[1]
G.A, K. and N.R. , R. 2025. THE USE OF EMPAGLYFLOSINE IN PATIENTS WITH CHRONIC CARDIAC FAILURE AND DYSFUNCTION OF THE KIDNEYS. Journal of Medical Genetics and Clinical Biology. 2, 12 (Oct. 2025), 602–606. DOI:https://doi.org/10.61796/jmgcb.v2i12.1477.